CIRS - The Centre for Innovation in Regulatory Science

Home
Member Login
Contact Us

The Centre for Innovation in Regulatory Science (CIRS) is a neutral, independent organisation conducting novel research, convening international forums for healthcare stakeholders and providing science-based insights to advance global regulatory and HTA policies and enhance patient access to medicines.

CIRS: The Centre for Innovation in Regulatory Science

About Us
Global Development Programme
HTA and Market Access Programme
OpERA
Workshops
- Past Workshops
- Upcoming Workshops
Publications
Decision Making
- Tools
  - CIRS-BRAT Framework
  - UMBRA Initiative

Slide of the Month

March 2018 Slide of the Month

CIRS Workshop participants organised the Ten Quality Decision-Making Practices according to their goals and specified necessary documentation.

Slide of the Month Archive >

CIRS NEWS

CIRS Senior Research Analyst Magda Bujar wins Margaret K B Day Prize

CONTACT US

Search our site

MEMBER LOGIN

Members have access to:
• Past Workshop Slides
• Atlas
and much more.
Login to our CIRS Member’s Section

CIRS 2018 AGENDA

Download the CIRS 2018 Agenda

Where to meet us

2018 CADTH Symposium: Managing Health Technologies: Supporting Appropriate, Affordable, and Accessible Care; 15-17 April 2018, Halifax Convention Centre, Halifax, Nova Scotia
HTAi 2018 Vancouver;1-5 June 2018; Westin Bayshore Hotel, Vancouver, Canada
DIA 2018; 24-28 June 2018; Boston Mass, US

READ

Our most recent publications

Walker S, McAuslane N, Bujar M, Connelly P, Liberti L. Quality decision-making practices: Their application and impact in the development, review and reimbursement of medicines. Netherlands: Off Page, 2017.

Liberti L. The practical application of regulatory science: Impact on regulatory policy and practice. Reg Rapporteur. 2018; 15:3-5-9.

CIRS R&D Briefing 66 The CIRS-BRAT Benefit-Risk Assessment Tool: Global use experience 2012-2017

CIRS R&D Briefing 65: New drug approvals in six major authorities 2007 – 2016 Focus on the internationalisation of medicines

Wang T, McAuslane N, Liberti L, Leufkens H, Hövels A. Building synergy between regulatory and HTA agencies beyond processes and procedures—Can we effectively align the evidentiary requirements? A survey of stakeholder perceptions. Value Health. DOI: http://dx.doi.org/10.1016/j.jval.2017.11.003

View more

© CIRS: The Centre for Innovation in Regulatory Science 2018

Centre for Innovation in Regulatory Science